| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 150,000 | 16 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | 16 Dec 2025 | 1 | $0 | 4 | Director | 18 Dec 2025, 16:43 |
| SABS | SAB Biotherapeutics, Inc. | 15 Jul 2024 | 1 | $0 | 4 | Director | 17 Jul 2024, 16:30 |
| SABS | SAB Biotherapeutics, Inc. | 13 Sep 2022 | 1 | $0 | 4 | Director | 15 Sep 2022, 17:00 |
| SABS | SAB Biotherapeutics, Inc. | 06 Jul 2022 | 0 | $0 | 3 | Director | 13 Jul 2022, 17:56 |